Ravulizumab in Pregnancy Shows No New Safety Signals in Global Analysis
A global pharmacovigilance analysis of 354 pregnancies found no unexpected safety signals with the complement inhibitor ravulizumab, with outcomes consistent ...
A global pharmacovigilance analysis of 354 pregnancies found no unexpected safety signals with the complement inhibitor ravulizumab, with outcomes consistent ...
Advanced susceptibility separation imaging reveals iron loss and myelin-related changes in the brain's U-fibers of multiple sclerosis patients that track ...
A long-term analysis of the N-MOmentum trial shows inebilizumab reduces NMOSD attack risk and disability worsening equally well in patients ...
A phase III trial of obinutuzumab β shows striking efficacy in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder, deepening questions about which ...
MOG antibody-associated disease, or MOGAD, is emerging from the margins of neuroimmunology as clinicians gain a more precise framework for ...
In the realm of infectious diseases, the interplay between viral infections and autoimmune disorders is a burgeoning field of study ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine